Artificial intelligence to deep learning: machine intelligence approach for drug discovery

R Gupta, D Srivastava, M Sahu, S Tiwari, RK Ambasta… - Molecular …, 2021 - Springer
Drug designing and development is an important area of research for pharmaceutical
companies and chemical scientists. However, low efficacy, off-target delivery, time …

Key topics in molecular docking for drug design

PHM Torres, ACR Sodero, P Jofily… - International journal of …, 2019 - mdpi.com
Molecular docking has been widely employed as a fast and inexpensive technique in the
past decades, both in academic and industrial settings. Although this discipline has now had …

Comparison of descriptor-and fingerprint sets in machine learning models for ADME-Tox targets

Á Orosz, K Héberger, A Rácz - Frontiers in Chemistry, 2022 - frontiersin.org
The screening of compounds for ADME-Tox targets plays an important role in drug design.
QSPR models can increase the speed of these specific tasks, although the performance of …

Property-unmatched decoys in docking benchmarks

RM Stein, Y Yang, TE Balius, MJ O'Meara… - Journal of chemical …, 2021 - ACS Publications
Enrichment of ligands versus property-matched decoys is widely used to test and optimize
docking library screens. However, the unconstrained optimization of enrichment alone can …

DeepCancerMap: a versatile deep learning platform for target-and cell-based anticancer drug discovery

J Wu, Y Xiao, M Lin, H Cai, D Zhao, Y Li, H Luo… - European Journal of …, 2023 - Elsevier
Discovering new anticancer drugs has been widely concerned and remains an open
challenge. Target-and phenotypic-based experimental screening represent two mainstream …

A multi-task FP-GNN framework enables accurate prediction of selective PARP inhibitors

D Ai, J Wu, H Cai, D Zhao, Y Chen, J Wei… - Frontiers in …, 2022 - frontiersin.org
PARP (poly ADP-ribose polymerase) family is a crucial DNA repair enzyme that responds to
DNA damage, regulates apoptosis, and maintains genome stability; therefore, PARP …

Ligand-and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia

H Zhang, J Huang, R Chen, H Cai, Y Chen, S He… - Bioorganic & Medicinal …, 2022 - Elsevier
Abstract Cyclin-dependent kinase 9 (CDK9) plays a vital role in controlling cell transcription
and has been an attractive target for cancer treatment. Herein, ten predictive models derived …

[HTML][HTML] Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning

A Rajput, A Thakur, A Mukhopadhyay, S Kamboj… - Computational and …, 2021 - Elsevier
The world is facing the COVID-19 pandemic caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2). Likewise, other viruses of the Coronaviridae family were …

Novel covalent and non-covalent complex-based pharmacophore models of SARS-CoV-2 main protease (Mpro) elucidated by microsecond MD simulations

Y Hayek-Orduz, AF Vásquez, MF Villegas-Torres… - Scientific Reports, 2022 - nature.com
As the world enters its second year of the pandemic caused by SARS-CoV-2, intense efforts
have been directed to develop an effective diagnosis, prevention, and treatment strategies …

Machine learning enables accurate and rapid prediction of active molecules against breast cancer cells

S He, D Zhao, Y Ling, H Cai, Y Cai, J Zhang… - Frontiers in …, 2021 - frontiersin.org
Breast cancer (BC) has surpassed lung cancer as the most frequently occurring cancer, and
it is the leading cause of cancer-related death in women. Therefore, there is an urgent need …